Tectonic Therapeutic (TECX) Shares Outstanding (2017 - 2026)
Tectonic Therapeutic's (TECX) quarterly Shares Outstanding (Entity) came in at $18.8 million in Q1 2026, up 0.85% year-on-year from $18.7 million in Q1 2025, and little changed on a QoQ basis from $18.7 million in Q4 2025.
Tectonic Therapeutic (TECX) Shares Outstanding (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 9 years of Shares Outstanding (Entity) data on file, last reported at $18.8 million in Q1 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 0.85% year-over-year to $18.8 million in Q1 2026; TTM through Mar 2026 was $18.8 million, a 0.85% increase from a year earlier, with the FY2025 full-year figure at $18.7 million, up 120.71% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $18.8 million, roughly flat from $18.7 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for TECX reached as high as $18.8 million in Q1 2026 and fell as low as $3641.0 in Q2 2022.
- Historically, Shares Outstanding (Entity) has averaged $8.1 million across 5 years, with a median of $3.7 million in 2023.
- Across the five-year window, Shares Outstanding (Entity) tumbled 99.9% in 2022 and surged 101985.54% in 2023, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $3645.0 in 2022, then jumped by 101985.54% to $3.7 million in 2023, then jumped by 128.17% to $8.5 million in 2024, then surged by 120.71% to $18.7 million in 2025, then rose by 0.49% to $18.8 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $18.8 million in Q1 2026, $18.7 million in Q4 2025, and $18.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 62.06 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 198.10 Mn |
| 10 | Tectonic Therapeutic | 571.52 Mn | 571.52 Mn | - | 18.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.77 Mn |
| Dec 31, 2025 | 18.32 Mn |
| Sep 30, 2025 | 18.71 Mn |
| Jun 30, 2025 | 18.68 Mn |
| Mar 31, 2025 | 17.16 Mn |
| Dec 31, 2024 | 8.49 Mn |
| Sep 30, 2024 | 14.73 Mn |
| Jun 30, 2024 | 2.92 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Dec 31, 2023 | 3.69 Mn |
| Sep 30, 2023 | 3.71 Mn |
| Jun 30, 2023 | 3.68 Mn |
| Mar 31, 2023 | 3,670.00 |
| Dec 31, 2022 | 3,645.00 |
| Sep 30, 2022 | 3,648.00 |
| Jun 30, 2022 | 3,641.00 |
| Mar 31, 2022 | 3.64 Mn |
| Dec 31, 2021 | 3.57 Mn |
| Sep 30, 2021 | 3.64 Mn |
| Jun 30, 2021 | 3.54 Mn |